Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
An isopropylalaninyl monoamidate phenyl monoester prodrug of tenofovir (GS 7340) was prepared, and its in vitro antiviral activity, metabolism, and pharmacokinetics in dogs were determined. The 50% effective concentration (EC 50 ) of GS 7340 against human immunodeficiency virus type 1 in MT-2 cells was 0.005 μM compared to an EC 50 of 5 μM for the parent drug, tenofovir. The ( L )-alaninyl analog (GS 7340) was >1,000-fold more active than the ( D )-alaninyl analog. GS 7340 has a half-life of 90 min in human plasma at 37°C and a half-life of 28.3 min in an MT-2 cell extract at 37°C. The antiviral activity (>10× the EC 50 ) and the metabolic stability in MT-2 cell extracts (>35×) and plasma (>2.5×) were also sensitive to the stereochemistry at the phosphorus. After a single oral dose of GS 7340 (10 mg-eq/kg tenofovir) to male beagle dogs, the plasma bioavailability of tenofovir compared to an intravenous dose of tenofovir was 17%. The total intracellular concentration of all tenofovir species in isolated peripheral blood mononuclear cells at 24 h was 63 μg-eq/ml compared to 0.2 μg-eq/ml in plasma. A radiolabeled distribution study with dogs resulted in an increased distribution of tenofovir to tissues of lymphatic origin compared to the commercially available prodrug tenofovir DF (Viread).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., & Fauci, A. S. (1993) · Nature · doi:10.1038/362355a0 · Cited by 1,808
Embretson, J., Zupancic, M., Ribas, J. L., Burke, A., Racz, P., Tenner-Racz, K., & Haase, A. T. (1993) · Nature · doi:10.1038/362359a0 · Cited by 1,419
Visualizing the generation of memory CD4 T cells in the whole body
Reinhardt, R. L., Khoruts, A., Merica, R., Zell, T., & Jenkins, M. K. (2001) · Nature · doi:10.1038/35065111 · Cited by 1,026 · cited 1×
“Intracellular half-life and distribution are particularly important because a significant fraction of memory CD4 T cells exists outside of lymphoid tissue (24).”
BackgroundWeislow, O. S., Kiser, R., Fine, D. L., Bader, J., Shoemaker, R. H., & Boyd, M. R. (1989) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.577 · Cited by 685
Furtado, M. R., Callaway, D. S., Phair, J. P., Kunstman, K. J., Stanton, J. L., Macken, C. A., Perelson, A. S., & Wolinsky, S. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905273402102 · Cited by 611
Ramratnam, B., Mittler, J. E., Zhang, L., Boden, D., Hurley, A., Fang, F., Macken, C. A., Perelson, A. S., Markowitz, M., & Ho, D. D. (2000) · Nature Medicine · doi:10.1038/71577 · Cited by 452
Zhang, H., Dornadula, G., Beumont, M., Livornese, L., Van Uitert, B., Henning, K., & Pomerantz, R. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392502 · Cited by 427
Balzarini, J., Holy, A., Jindrich, J., Naesens, L., Snoeck, R., Schols, D., & De Clercq, E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.332 · Cited by 350
Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents
Pauwels, R., Balzarini, J., Schols, D., Baba, M., Desmyter, J., Rosenberg, I., Holy, A., & De Clercq, E. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.7.1025 · Cited by 256
Lewin, S. R., Vesanen, M., Kostrikis, L., Hurley, A., Duran, M., Zhang, L., Ho, D. D., & Markowitz, M. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6099-6103.1999 · Cited by 253
Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection: A Randomized Trial
Squires, K., Pozniak, A. L., Pierone, G., Steinhart, C. R., Berger, D., Bellos, N. C., Becker, S. L., Wulfsohn, M., Miller, M. D., Toole, J. J., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00006 · Cited by 198
Deeks, S. G., Barditch-Crovo, P., Lietman, P. S., Hwang, F., Cundy, K. C., Rooney, J. F., Hellmann, N. S., Safrin, S., & Kahn, J. O. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2380 · Cited by 158
Self-citationRamratnam, B., Ribeiro, R. M., Tian, H., Chung, C., Simon, V. R., Vanderhoeven, J., Hurley, A., Zhang, L., Perelson, A. S., Ho, D. D., et al. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200401010-00004 · Cited by 120
Segel, G., Cokelet, G., & Lichtman, M. A. (1981) · Blood · doi:10.1182/blood.v57.5.894.894 · Cited by 103
Yerly, S., Perneger, T., Vora, S., Hirschel, B. J., & Perrin, L. H. (2000) · AIDS · doi:10.1097/00002030-200012220-00001 · Cited by 102
Cell volumes of normal and malignant mononuclear cells.
Chapman, E. H., Kurec, A. S., & Davey, F. R. (1981) · Journal of Clinical Pathology · doi:10.1136/jcp.34.10.1083 · Cited by 69
A simple relationship between viral load and survival time in HIV-1 infection
Arnaout, R., Lloyd, A. L., OʼBrien, T. R., Goedert, J. J., Leonard, J. M., & Nowak, M. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11549 · Cited by 60
Pompon, A., Lefèbvre, I., Imbach, J., Kahn, S., & Farquhar, D. (1994) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029400500205 · Cited by 45
Cited by
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Jordheim, L. P., Durantel, D., Zoulim, F., & Dumontet, C. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4010 · Cited by 1,211
Acyclic nucleoside phosphonates: a key class of antiviral drugs
Clercq, E. D., & Holý, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1877 · Cited by 688
Siegel, D., Hui, H. C., Doerffler, E., Clarke, M. O., Chun, K., Zhang, L., Neville, S., Carra, E., Lew, W., Ross, B., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01594 · Cited by 643
Self-citationAgarwal, K., Brunetto, M., Seto, W. K., Lim, Y.-S., Fung, S., Marcellin, P., Ahn, S. H., Izumi, N., Chuang, W., Bae, H., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.039 · Cited by 428
Prodrugs of Phosphates and Phosphonates
Hecker, S. J., & Erion, M. D. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701260b · Cited by 414
Metadata
- Authors
- Lee, W. A., He, G.-X., Eisenberg, E., Cihlar, T., Swaminathan, S., Mulato, A., & Cundy, K. C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2005-05
- Volume
- 49
- Issue
- 5
- Pages
- 1898-1906
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1970506670
- Cited by
- 338
- References
- 20
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.